Therapeutic Strategies in Medical Management of Peptic Ulcer Disease

  • M. Gregor
Conference paper

Abstract

So far, all speakers in this symposium have focussed mainly on the harmful effects of gastric acidity on the gastric and duodenal mucosa. On the other hand, the assumed pathogenicity of Campylobacter pylori has opened a new perspective in the treatment of peptic ulcer disease. It may well be that the combined treatment of gastric acidity of C. pylori-colonization will display a synergistic effect in ulcer healing. However, since all the following presentations will give more details about C. pylori-colonization and eradication, we feel it is still necessary to highlight briefly the hitherto and conventional treatment of peptic ulcer disease.

Keywords

Placebo Nitrite Histamine Bismuth Perforation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boyd EJS, Wormsley KG (1985) Etiology and pathogenesis of peptic ulcer. In: Berk JE (ed) Bockus Gastroenterology, vol 2. WB Saunders, Philadelphia, pp 1013–1059Google Scholar
  2. 2.
    Malchow H, Sewing K-F, Albinus M, Horn B, Schomerus H, Dölle W (1978) Cimetidin in der stationären Behandlung des peptischen Ulkus. I. Wirkung auf die Heilung des Ulcus duodeni. Dtsch Med Wochenschr 103:149–152Google Scholar
  3. 3.
    Scheurer U, Witzel L, Halter F, Keller HM, Huber R, Galaeazzi R (1977) Gastric and duodenal ulcer healing and placebo treatment. Gastroenterology 72:838–851PubMedGoogle Scholar
  4. 4.
    Multicentre trial: the effect of cimetidine on duodenal ulceration (1977) In: Burland WL, Simkins MA (eds) Cimetidine. Excerpta Medica, Amsterdam, pp 260–271Google Scholar
  5. 5.
    Dobrilla G (1983) Placebo in the evaluation of antiulcer drugs. Int J Tissue React 5:329–337PubMedGoogle Scholar
  6. 6.
    Pounder RE (1981) Model of medical treatment for duodenal ulcer. Lancet I:29–30CrossRefGoogle Scholar
  7. 7.
    Bardhan KD (1980) Intermittent treatment of duodenal ulcer with cimetidine. Br Med J 281:20–22PubMedCrossRefGoogle Scholar
  8. 8.
    Thompson ABR, Mahachai V (1985) Medical management of uncomplicated peptic ulcer disease. In: Berk JE (ed) Bockus Gastroenterology, vol 2. WB Saunders, Philadelphia, pp 1116–1154Google Scholar
  9. 9.
    Kurata JH, Haile BM (1984) Epidemiology of peptic ulcer disease. In: Isenberg JI, Johansson C (eds) Peptic ulcer disease. WB Saunders, London, pp 289–308 (Clinics in Gastroenterology, vol 13:2)Google Scholar
  10. 10.
    Bonnevie O (1977) Causes of death in duodenal and gastric ulcer. Gastroenterology 73:1000–1004PubMedGoogle Scholar
  11. 11.
    Bonnevie O (1978) Survival in peptic ulcer. Gastroenterology 75:1055 –1060PubMedGoogle Scholar
  12. 12.
    Pulvertraft CN (1968) Comments on the incidence and natural history of gastric and duodenal ulcer. Postgrad Med J 44:597–602CrossRefGoogle Scholar
  13. 13.
    Berstad A, Weberg R (1986) Antacids in the treatment of gastroduodenal ulcer. Scand J Gastroenterol 21:385–391PubMedCrossRefGoogle Scholar
  14. 14.
    Friedman G (1987) Omeprazole. Am J Gastroenterol 83:188–191Google Scholar
  15. 15.
    Clissold SP, Campli-Richards DM (1986) Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32:15–47PubMedCrossRefGoogle Scholar
  16. 16.
    Walan A (1984) Antacids and anticholinergics in the treatment of duodenal ulcer. In: Isenberg JI, Johansson C (eds) Peptic ulcer disease. WB Saunders, London, pp 473–499 (Clinics in Gastroenterology, vol 13:2)Google Scholar
  17. 17.
    Brogden RN, Heel RC, Speight TM, Avery GS (1984) Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs 27:194–209PubMedCrossRefGoogle Scholar
  18. 18.
    Carmine AA, Brogden RN (1985) Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs 30:85–126PubMedCrossRefGoogle Scholar
  19. 19.
    Tytgat GNJ, Hameeteman W, Van Olffen GH (1984) Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer. In: Isenberg JI, Johansson C (eds) Peptic ulcer disease. WB Saunders, London, pp 543–568 (Clinics in Gastroenterology, vol 13:2)Google Scholar
  20. 20.
    Monk JP, Clissold SP (1987) Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 33:1–30PubMedCrossRefGoogle Scholar
  21. 21.
    Thompson ABR (ed) (1986) Protective and therapeutic effects of gastrointestinal prostaglandins. Enprostil: a new modality. Am J Med 81 (2A): 1–88Google Scholar
  22. 22.
    Campoli-Richards DM, Clissold SP (1986 ) Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32:197–221PubMedCrossRefGoogle Scholar
  23. 23.
    Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS (1982) Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24:267–303PubMedCrossRefGoogle Scholar
  24. 24.
    Meyrick TJ, Misiewicz G (1984) Histamine H2-receptor antagonists in the short- and longterm treatment of duodenal ulcer. In: Isenberg JI, Johansson C (eds) Peptic ulcer disease. WB Saunders, London, pp 501–543 (Clinics in Gastroenterology, vol 13:2)Google Scholar
  25. 25.
    Ruddell WSJ, Axon ATR, Findlay JM, Bartholomew BA, Hill MJ (1980) Effect of cimetidine on the gastric bacterial flora. Lancet I:672–674Google Scholar
  26. 26.
    Sharma BK, Santana JA, Wood EC, Walt RP, Pereira M, Noone P, Smith PLR, Walters CL, Pounder RE (1984) Intragastric bacterial activity and nitrosation before, during and after treatment with omeprazole. Br Med J 289:717–719CrossRefGoogle Scholar
  27. 27.
    Merson MH, Ouchterlony O, Holmgren J (eds) (1980) In: Cholera and related diarrhoeas. Karger, Basel, pp 34–45Google Scholar
  28. 28.
    Milton-Thompson GJ, Lightfoot NF, Ahmet L (1982 ) Intragastric acidity, bacteria, nitrite and yV-nitroso compounds before, during and after cimetidine treatment. Lancet I:1091–1095CrossRefGoogle Scholar
  29. 29.
    Howden CW, Hunt RH (1987) Relationship between gastric secretion and infection. Gut 28:96–107PubMedCrossRefGoogle Scholar
  30. 30.
    Stockmann R, Fölsch UR, Bonatz G, Wulfrath M, Creutzfeldt W (1984) Influence of a substituted benzimidazole (omeprazole) on rat gastric endocrine cells. Dig Dis Sci 29:83 SGoogle Scholar
  31. 31.
    Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C (1985) Toxicological studies on omeprazole. Scand J Gastroenterol [Suppl] 108:53–69Google Scholar
  32. 32.
    Hakanson R, Sundler F, Carlsson E, Mattson H, Larsson H (1986) Proliferation of enterochromaffln-like (ECL) cells in the rat stomach following omeprazole treatment. Hepatogastroenterol 32:48–49Google Scholar
  33. 33.
    Wormsley KG (1984) Assessing the safety of drugs for the long-term treatment of peptic ulcer. Gut 25:1416–1423PubMedCrossRefGoogle Scholar
  34. 34.
    Penston J, Wormsley KG (1987) Achlorhydria: hypergastrinaemia: carcinoids - a flawed hypothesis? Gut 28:488–505PubMedCrossRefGoogle Scholar
  35. 35.
    Martin DF, Hollanders D, May SJ, Ravenscroft MM, Tweedle DEF, Miller JP (1981) Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1:7–10PubMedCrossRefGoogle Scholar
  36. 36.
    Hamilton I, O’Connor HJ, Wood NC, Bradbury I, Axon ATR (1986) Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut 27:106–110PubMedCrossRefGoogle Scholar
  37. 37.
    Tytgat GNJ (1987 ) Colloidal bismuth subcitrate in peptic ulcer - a review. Digestion 37 [Suppl 2]:31–41PubMedCrossRefGoogle Scholar
  38. 38.
    Colin-Jones DG (1986) There is more to healing ulcers than suppressing acid. Gut 27:475–480PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • M. Gregor

There are no affiliations available

Personalised recommendations